Καναδάς - Αγγλικά - Health Canada

cobalt pharmaceuticals company - alendronic acid (alendronate sodium trihydrate) - tablet - 70mg - alendronic acid (alendronate sodium trihydrate) 70mg - bone resorption inhibitors

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - alendronate sodium -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - alendronate sodium -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - alendronate sodium -

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

a-s medication solutions - alendronate sodium (unii: 2uy4m2u3ra) (alendronic acid - unii:x1j18r4w8p) - alendronate sodium tablets are indicated for the treatment of osteoporosis in postmenopausal women. in postmenopausal women, alendronate sodium tablets increase bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). [see clinical studies (14.1) .] alendronate sodium tablets are indicated for the prevention of postmenopausal osteoporosis [see clinical studies (14.2) ].   alendronate sodium tablets are indicated for treatment to increase bone mass in men with osteoporosis [see clinical studies (14.3) ].   alendronate sodium tablets are indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density [see clinical studies (14.4) ].   alendronate sodium tablets are indicated for the treatment of paget’s disease of bone in men and women. treatment is indicated in patients with paget's disease of bone

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

amneal pharma australia pty ltd - alendronate sodium -

Ηνωμένες Πολιτείες - Αγγλικά - NLM (National Library of Medicine)

a-s medication solutions - alendronate sodium (unii: 2uy4m2u3ra) (alendronic acid - unii:x1j18r4w8p) - alendronate sodium tablets, usp are indicated for the treatment of osteoporosis in postmenopausal women. in postmenopausal women, alendronate sodium tablets, usp increase bone mass and reduces the incidence of fractures, including those of the hip and spine (vertebral compression fractures). [see clinical studies (14.1).] alendronate sodium tablets, usp are indicated for the prevention of postmenopausal osteoporosis [see clinical studies (14.2)] . alendronate sodium tablets, usp are indicated for treatment to increase bone mass in men with osteoporosis [see clinical studies (14.3)] . alendronate sodium tablets, usp are indicated for the treatment of glucocorticoid-induced osteoporosis in men and women receiving glucocorticoids in a daily dosage equivalent to 7.5 mg or greater of prednisone and who have low bone mineral density [see clinical studies (14.4)] . alendronate sodium tablets, usp are indicated for the treatment of paget's disease of bone in men and women. treatment is indicated in patients with page

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - alendronate sodium,colecalciferol -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - alendronate sodium,colecalciferol -

Αυστραλία - Αγγλικά - Department of Health (Therapeutic Goods Administration)

dr reddys laboratories australia pty ltd - alendronate sodium,colecalciferol,calcium carbonate,microcrystalline cellulose -